PharmX Technologies Limited

ASX:PHX Stock Report

Market Cap: AU$43.7m

PharmX Technologies Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

ASX:PHX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
12 Feb 24BuyAU$1,913Philip EnglandIndividual127,500AU$0.015

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of PHX?
Owner TypeNumber of SharesOwnership Percentage
Institutions52,880,7418.84%
Private Companies158,037,65926.4%
Individual Insiders190,136,42331.8%
General Public197,451,96633%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 23 shareholders own 67.01% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
15%
Lujeta Pty Ltd.
89,480,946AU$6.5m0%no data
10%
Dennis Bastas
60,000,000AU$4.4m0%no data
4.69%
Lyell Pty Ltd
28,055,640AU$2.0m0%no data
4.63%
Australian Ethical Investment Limited
27,727,691AU$2.0m-31.1%0.19%
4.51%
Philip England
26,980,834AU$2.0m0%no data
2.63%
Cyan Investment Management Pty Ltd
15,761,905AU$1.2m0%18.91%
2.61%
John Lagana
15,621,734AU$1.1m0%no data
2.41%
Thomas Klinger
14,414,488AU$1.1m0%no data
2.23%
David Manuel
13,333,334AU$973.3k0%no data
2.23%
Penelope King
13,333,334AU$973.3k0%no data
2.23%
Anne Leary
13,333,333AU$973.3k0%no data
2%
Grant Povey
12,000,000AU$876.0k0%no data
2%
Seveniron Pty Ltd
12,000,000AU$876.0k0%no data
1.86%
Benki Pty Ltd
11,103,739AU$810.6k-35.1%no data
1.7%
Canceler Pty Ltd
10,200,000AU$744.6k0%no data
1.57%
DMX Asset Management Limited
9,391,145AU$685.6k0%3.03%
1.34%
Tyson Wellman
8,000,000AU$584.0k0%no data
1.2%
Gabodi Pty Limited
7,197,334AU$525.4k0%no data
0.67%
Helen Thomas
4,000,000AU$292.0k11.9%no data
0.67%
Peter Thomas
4,000,000AU$292.0k11.9%no data
0.46%
Jayne Shaw
2,780,953AU$203.0k0%no data
0.29%
Andrew Jonathan Newbery
1,713,413AU$125.1k0%no data
0.1%
Zoe Hillier
625,000AU$45.6k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 22:10
End of Day Share Price 2024/12/24 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

PharmX Technologies Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Caleb WengPAC Partners Securities Pty. Ltd.